DYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUSDYSLIPIDEMIA IN TYPE 2 DIABETES MELLITUS
Journal Title: Acta HealthMedica - Year 2018, Vol 3, Issue 1
Abstract
Background: Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL- cholesterol particles. The objective of this work was to define and characterize the lipid profile of type 2 diabetic patients Methods: A series of 30 patients was selected for the study of the lipid profile; the classic methods were used for the determination of triglycerides, total cholesterol, C-HDL, and C-LDL. Results: According to our results, all our patients had hyperglycemia, our patients had a body weight ≥ 80 kg, with an overweight of 88% in women and 86.4% in men. All our patients had dyslipidemia with high levels of triglycerides and total cholesterol. Conclusion: Lipid abnormalities are part of the metabolic disease and contribute to the increased cardiovascular risk of type 2 diabetes, intensive treatment of dyslipidemia becomes an absolute obligation in the cardiovascular prevention of these patients.
Authors and Affiliations
Youb Imane, Missoun Fatiha, Karamane souad, Bouabedelli Fatma, Benhamimed El attafia, Djebli Noureddine
SINGLE AUTHOR PAPERS IN MASHHAD UNIVERSITY OF MEDICAL SCIENCES (MUMS) IN THE RECENT 10 YEARS
Introduction: Bibliometric analysis can explore the patterns of authorship. The single authorship is an unpleasant phenomenon in research, and we investigate the single author papers’ trend in Mashhad University of Medic...
PERSIAN REGISTRY OF CARDIOVASCULAR DISEASE (PROVE)
Introduction: The Persian Registry Of cardioVascular diseasE (PROVE) aimed to study the demographic, clinical, diagnosis and treatment of patients with cardiovascular disease (CVD) and to follow them for 1 to 3 years, l...
GENETIC EPIDEMIOLOGICAL CHARACTERIZATION OF THE POPULATION OF TLEMCEN (WEST ALGERIA) BY TYPE 1 DIABETES
Background: Type 1 diabetes is a real public health problem, concerning not only its complications and cost, but also its increasing incidence and the fact that it occurs in young people. The objective of this study is t...
FASA REGISTRY FOR SYSTOLIC HEART FAILURE (FARSH), FEASIBILITY STUDY
Background: Systolic heart failure (SHF), as a highly prevalent disease with serious costs to the health system, is becoming one of the major challenges for health policy makers. Every attempt to define treatment pattern...
EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN PREVENTION OF PRETERM NEONATAL SEPSIS: A CLINICAL TRIAL STUDY
Background: The incidence of severe sepsis and septic shock is higher among preterm infants. Prevention of neonatal sepsis has remained a global challenge in recent decades. The role of intravenous immunoglobulin (IVIG)...